Hisamitsu Pharmaceutical Co (TSE:4530) Shiller PE Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4530 Hisamitsu Pharmaceutical Co Inc TSE:4530
69 GF Score
Price 円6,040.00
GF Value 円4,918.72
View Full Analysis

What is Hisamitsu Pharmaceutical Co Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Hisamitsu Pharmaceutical Co  (TSE:4530) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Hisamitsu Pharmaceutical Co Shiller PE Ratio Related Terms


Hisamitsu Pharmaceutical Co Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Hisamitsu Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hisamitsu Pharmaceutical Co Shiller PE Ratio Chart

Hisamitsu Pharmaceutical Co Annual Data
Trend Feb17 Feb18 Feb19 Feb20 Feb21 Feb22 Feb23 Feb24 Feb25 Feb26
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.34 18.32 18.94 19.50 27.13

Hisamitsu Pharmaceutical Co Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.45 18.85 19.39 19.68 27.05

TSE:4530 vs AMPH, ESPR, NIKA: Shiller PE Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hisamitsu Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's Shiller PE Ratio falls into.


TSE:4530
69GF Score
Hisamitsu Pharmaceutical Co Inc TSE:4530
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hisamitsu Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Hisamitsu Pharmaceutical Co's E10 for the quarter that ended in Feb. 2026 is calculated as:

For example, Hisamitsu Pharmaceutical Co's adjusted earnings per share data for the three months ended in Feb. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Feb. 2026 (Change)*Current CPI (Feb. 2026)
=102.642/112.2000*112.2000
=102.642

Current CPI (Feb. 2026) = 112.2000.

Hisamitsu Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201605 53.470 98.200 61.093
201608 55.947 97.900 64.118
201611 106.700 98.600 121.417
201702 24.560 98.100 28.090
201705 43.890 98.600 49.944
201708 68.226 98.500 77.716
201711 77.078 99.100 87.267
201802 39.154 99.500 44.151
201805 41.225 99.300 46.580
201808 68.135 99.800 76.601
201811 49.836 100.000 55.916
201902 70.655 99.700 79.514
201905 23.117 100.000 25.938
201908 68.149 100.000 76.463
201911 95.874 100.500 107.036
202002 40.091 100.300 44.848
202005 1.382 100.100 1.549
202008 43.774 100.100 49.066
202011 24.808 99.500 27.974
202102 43.136 99.800 48.496
202105 28.879 99.400 32.598
202108 32.279 99.700 36.325
202111 14.910 100.100 16.712
202202 42.753 100.700 47.636
202205 20.439 101.800 22.527
202208 61.061 102.700 66.709
202211 37.855 103.900 40.879
202302 28.390 104.000 30.628
202305 52.036 105.100 55.552
202308 56.189 105.900 59.532
202311 48.417 106.900 50.817
202402 24.544 106.900 25.760
202405 63.812 108.100 66.232
202408 58.737 109.100 60.406
202411 62.212 110.000 63.456
202502 110.392 110.800 111.787
202505 35.100 111.800 35.226
202508 61.781 112.100 61.836
202511 68.689 113.200 68.083
202602 102.642 112.200 102.642

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Hisamitsu Pharmaceutical Co (TSE:4530) Overvalued in 2026?

Based on GuruFocus' analysis, Hisamitsu Pharmaceutical Co stock appears to be overvalued. The current stock price of 円6,040.00 is trading 22.8% above its estimated GF Value™ of 円4,918.72.

Key valuation signals for TSE:4530:

  • Shiller PE Ratio:
  • GF Value™: 円4,918.72 vs. price of 円6,040.00 (22.8% above fair value)
  • GF Score™: 69/100

No single metric tells the full story. See the TSE:4530 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hisamitsu Pharmaceutical Co Business Description

Other Exchanges HTSUY:USA
Address 408 Tashiro Daikancho, Saga Prefecture, Tosu, JPN, 841-0017
Hisamitsu Pharmaceutical Co Inc is engaged in the research, development, manufacturing, procurement, and sale of pharmaceutical products. The company operates a single business segment, focusing on medical and general pharmaceuticals both in Japan and overseas. It markets drugs under the Salonpas, Nobinobi / Salonsip, Butenalock, and Mohrus brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions, and ointments.
69GF Score

Get the complete analysis for TSE:4530

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円6,040.00
Price
円4,918.72
GF Value